CSPC Pharmaceutical Group Limited
CSPCY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $7 | $8 | $12 |
| Short-Term Investments | $2 | $1 | $2 | $1 |
| Receivables | $9 | $10 | $12 | $10 |
| Inventory | $3 | $3 | $3 | $3 |
| Other Curr. Assets | $0 | $0 | $0 | -$0 |
| Total Curr. Assets | $23 | $22 | $26 | $27 |
| Property Plant & Equip (Net) | $14 | $13 | $12 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $3 | $2 | $2 |
| Long-Term Investments | $1 | $5 | $6 | $5 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $2 | $0 | $0 |
| Total NC Assets | $23 | $23 | $21 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $46 | $44 | $48 | $46 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $0 | $0 |
| Total Curr. Liab. | $10 | $10 | $10 | $10 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $1 | $1 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $11 | $11 | $11 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $1 |
| Common Stock | $11 | $11 | $11 | $11 |
| Retained Earnings | $25 | $23 | $25 | $22 |
| AOCI | $0 | $0 | $0 | -$1 |
| Other Equity | -$2 | -$2 | -$1 | $0 |
| Total Equity | $33 | $32 | $35 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2 | $2 | $2 | $2 |
| Total Liab. & Tot. Equity | $46 | $44 | $48 | $46 |
| Net Debt | -$7 | -$6 | -$8 | -$12 |